Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemia”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Early research (Phase 1)Enrolling By InvitationNCT07495514
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers

Who this might be right for
Mixed DyslipidemiaFood Effect Study of AD-117
Addpharma Inc. 60
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Large-scale testing (Phase 3)WithdrawnNCT05809687
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Who this might be right for
Dyslipidemias
Dongkwang Pharm. Co., Ltd.
Not applicableLooking for participantsNCT06752772
What this trial is testing

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Who this might be right for
Elevated Blood PressureHypertensionOverweight/Obesity+3 more
Alexandra Hospital 1,700
Early research (Phase 1)Not Yet RecruitingNCT07152873
What this trial is testing

Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 60
Not applicableStudy completedNCT07409636
What this trial is testing

Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 11,991
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Testing effectiveness (Phase 2)Looking for participantsNCT07223658
What this trial is testing

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Who this might be right for
Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals 78
Not applicableLooking for participantsNCT06770543
What this trial is testing

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 1,500
Not applicableWithdrawnNCT05798390
What this trial is testing

Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Testing effectiveness (Phase 2)Study completedNCT04832971
What this trial is testing

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Arrowhead Pharmaceuticals 204
Testing effectiveness (Phase 2)Looking for participantsNCT06797401
What this trial is testing

Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia

Who this might be right for
Dyslipidemias
Ribocure Pharmaceuticals AB 120
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Not applicableStudy completedNCT04063137
What this trial is testing

Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals

Who this might be right for
Postprandial HyperglycemiaLipidemia
National University of Singapore 24
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Large-scale testing (Phase 3)Looking for participantsNCT05621070
What this trial is testing

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd. 582
Large-scale testing (Phase 3)Study completedNCT00092560
What this trial is testing

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 587
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Large-scale testing (Phase 3)Looking for participantsNCT05400317
What this trial is testing

Evaluate the Efficacy and Safety of AD-218

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 520
Load More Results